Chamomile Apigenin, CAS# 520-36-5, is a Plant extracts manufactured through plant extraction, available as Light Yellow Powder. Chamomile Apigenin is widely used as nutrition supplements. It is widely accepted as safe food additive in many countries.
No significant side effects reported.
As Chamomile Apigenin Side Effects is widely known as safe, there is no limit on dosage of intake. However, we still recommend consumers to consult professionals before using large quantity of Chamomile Apigenin Side Effects for long period.
Special groups refer to newborns, children, pregnant and any other applicable vulnerable groups.
There is no evidence that Chamomile Apigenin Side Effects could have any negative effects on these vulnerable groups. It should be safe to use Chamomile Apigenin Side Effects in food for newborns and pregnant. However, we still recommend consumers to consult professionals before using large quantity of Chamomile Apigenin Side Effects for long period in food for newborns or pregnant.
Though Chamomile Apigenin Side Effects is not on FDA's GRAS exemption list, it's still widely accepted as safe food additive in many countries including USA with specific limit on dosage.
No health issues about Chamomile Apigenin Side Effects reported up to now.
1. Apigenin and Breast Cancers: From Chemistry to Medicine. [Anticancer Agents Med Chem. 2015]
Author: Nabavi SM, Habtemariam S, Daglia M, Nabavi SF.
2. Development and validation of an HPTLC method for apigenin 7-O-glucoside in chamomileflowers and its application for fingerprint discrimination of chamomile-like materials. [J Pharm Biomed Anal. 2015 Mar 25]
Author: Guzelmeric E, Vovk I, Yesilada E.
3. Exposure of breast cancer cells to a subcytotoxic dose of apigenin causes growth inhibition, oxidative stress, and hypophosphorylation of Akt. [Exp Mol Pathol. 2014 Oct]
Author: Harrison ME, Power Coombs MR, Delaney LM, Hoskin DW.
4. Apigenin has anti-atrophic gastritis and anti-gastric cancer progression effects in Helicobacter pylori-infected Mongolian gerbils. [J Ethnopharmacol. 2014 Feb 12]
Author: Kuo CH, Weng BC, Wu CC, Yang SF, Wu DC, Wang YC.